{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:53:19Z","timestamp":1764078799198},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T00:00:00Z","timestamp":1289952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00726-010-0804-z","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T18:48:08Z","timestamp":1289846888000},"page":"261-269","source":"Crossref","is-referenced-by-count":23,"title":["CNS delivery of l-dopa by a new hybrid glutathione\u2013methionine peptidomimetic prodrug"],"prefix":"10.1007","volume":"42","author":[{"given":"Francesco","family":"Pinnen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Cacciatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catia","family":"Cornacchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Sozio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura S.","family":"Cerasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Iannitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Nasuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,17]]},"reference":[{"key":"804_CR1","doi-asserted-by":"crossref","unstructured":"Angelini G, Cusan C, De Maria P, Fontana A, Maggini M, Pierini M, Prato M, Schergna S, Villani C (2005) The associative properties of some amphiphilic fullerene derivatives. Eur J Org Chem 9:1884\u20131891","DOI":"10.1002\/ejoc.200400699"},{"key":"804_CR2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1023\/A:1016239321494","volume":"12","author":"JPF Bai","year":"1995","unstructured":"Bai JPF (1995) pGlu-l-Dopa-Pro: a tripeptide prodrug targeting the intestinal peptide transporter for absorption and tissue enzymes for conversion. Pharm Res 12:1101\u20131104","journal-title":"Pharm Res"},{"key":"804_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bmc.706","volume":"21","author":"M Bajda","year":"2007","unstructured":"Bajda M, Boryczka S, Wietrzyk J, Malawska B (2007) Investigation of lipophilicity of anticancer-active thioquinoline derivatives. Biomed Chromatogr 21:123\u2013131","journal-title":"Biomed Chromatogr"},{"key":"804_CR4","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.1021\/ja072301f","volume":"129","author":"K Bobrowski","year":"2007","unstructured":"Bobrowski K, Hug GL, Pogocki D, Marciniak B, Sch\u00f6neich C (2007) Sulfur radical cation-peptide bond complex in the one-electron oxidation of S-methylglutathione. J Am Chem Soc 129:9236\u20139245","journal-title":"J Am Chem Soc"},{"key":"804_CR5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/jm00221a014","volume":"20","author":"N Bodor","year":"1977","unstructured":"Bodor N, Sloan KB, Higuchi T, Sasaha K (1977) Improved delivery through biological membranes. 4. Prodrugs of l-DOPA. J Med Chem 20:1435\u20131445","journal-title":"J Med Chem"},{"key":"804_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(96)04728-X","volume":"145","author":"F Bonina","year":"1996","unstructured":"Bonina F, Lanza M, Montenegro L, Puglisi G, Tomaino A, Trombetta D, Castelli F, Saija A (1996) Flavonoids as potential protective agents against photo-oxidative skin damage. Int J Pharm 145:87\u201394","journal-title":"Int J Pharm"},{"key":"804_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.aca.2004.01.025","volume":"511","author":"G Burini","year":"2004","unstructured":"Burini G, Coli R (2004) Determination of formaldehyde in spirits by high-performance liquid chromatography with diode-array detection after derivatization. Anal Chim Acta 511:155\u2013158","journal-title":"Anal Chim Acta"},{"key":"804_CR8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0960-894X(00)00249-3","volume":"10","author":"GM Cingolani","year":"2000","unstructured":"Cingolani GM, Di Stefano A, Mosciatti B, Napolitani F, Giorgioni G, Ricciutelli M, Claudi F (2000) Synthesis of l-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2, 5-diketomorpholine as potential prodrug of l-dopa. Bioorg Med Chem Lett 10:1385\u20131388","journal-title":"Bioorg Med Chem Lett"},{"key":"804_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00002826-198403000-00005","volume":"7","author":"DR Cooper","year":"1984","unstructured":"Cooper DR, Marrel C, Van De Waterbeemd H, Quinn N, Testa B, Jenner P, Marsden CD (1984) l-Dopa methyl ester-a candidate for chronic systemic delivery of l-dopa in Parkinson\u2019s disease. Clin Neuropharmacol 7:89\u201398","journal-title":"Clin Neuropharmacol"},{"key":"804_CR10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.2042-7158.1987.tb05123.x","volume":"39","author":"DR Cooper","year":"1987","unstructured":"Cooper DR, Marrel C, Van De Waterbeemd H, Testa B, Jenner P, Marsden CD (1987) l-Dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized mice. J Pharm Pharmacol 39:809\u2013818","journal-title":"J Pharm Pharmacol"},{"key":"804_CR11","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1021\/jm051145p","volume":"49","author":"A Di Stefano","year":"2006","unstructured":"Di Stefano A, Sozio P, Cocco A, Iannitelli A, Santucci E, Costa M, Pecci L, Nasuti C, Cantalamessa F, Pinnen F (2006) l-Dopa- and dopamine-(R)-\u03b1-Lipoic acid conjugates as multifunctional codrugs with antioxidant properties. J Med Chem 49:1486\u20131493","journal-title":"J Med Chem"},{"key":"804_CR12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejps.2008.02.123","volume":"34","author":"A Di Stefano","year":"2008","unstructured":"Di Stefano A, Sozio P, Iannitelli A, Cerasa LS, Fontana A, Di Biase G, D\u2019Amico G, Di Giulio M, Carentiero C, Grumetto L, Barbato F (2008) Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disorders. Eur J Pharm Sci 34:118\u2013128","journal-title":"Eur J Pharm Sci"},{"key":"804_CR13","first-page":"23","volume-title":"Drug targeting-organ specific strategies","author":"M Everts","year":"2001","unstructured":"Everts M, Schraa AJ, de Leij LFMH, Meijer DKF, Molema G (2001) Brain-specific drug targeting strategies. In: Molema G, Meijer DKF (eds) Drug targeting-organ specific strategies. Wiley-VCH, Weinheim, pp 23\u201352"},{"key":"804_CR14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/jm00155a018","volume":"29","author":"A Garzon-Aburbeh","year":"1986","unstructured":"Garzon-Aburbeh A, Poupaert JH, Claesen M, Dumont PA (1986) Lymphotropic prodrug of l-dopa: synthesis, pharmacological properties, and pharmacokinetic behavior of 1, 3-dihexadecanoyl-2-[(S)-2-amino-3-(3, 4-dihydroxyphenyl)prop anoyl] propane-1, 2, 3-triol. J Med Chem 29:687\u2013691","journal-title":"J Med Chem"},{"key":"804_CR15","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.bmc.2010.01.041","volume":"18","author":"G Giorgioni","year":"2010","unstructured":"Giorgioni G, Claudi F, Ruggieri S, Ricciutelli M, Palmieri GF, Di Stefano A, Sozio P, Cerasa LS, Chiavaroli A, Ferrante C, Orlando G, Glennon RA (2010) Design, synthesis and preliminary pharmacological evaluation of new imidazolinones as l-DOPA prodrugs. Bioorg Med Chem 18:1834\u20131843","journal-title":"Bioorg Med Chem"},{"key":"804_CR16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jps.2600780703","volume":"78","author":"M Ihara","year":"1989","unstructured":"Ihara M, Tsuchiya Y, Sawasaki Y, Hisaka A, Takehana H, Tomimoto K, Yano MA (1989) New potential prodrug to improve the duration of l-dopa: l-3-(3-hydroxy-4-pivaloyloxyphenyl)-alanine. J Pharm Sci 78:525\u2013529","journal-title":"J Pharm Sci"},{"key":"804_CR17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.53.5.1012","volume":"53","author":"WC Koller","year":"1999","unstructured":"Koller WC, Hutton JT, Tolosa E, Capilldeo R (1999) Immediate-release and controlled-release carbidopa\/levodopa in PD: a 5-year randomized multicenter study. Neurology 53:1012\u20131019","journal-title":"Neurology"},{"key":"804_CR18","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1056\/NEJMct0800326","volume":"359","author":"PA LeWitt","year":"2008","unstructured":"LeWitt PA (2008) Levodopa for the treatment of Parkinson\u2019s disease. N Engl J Med 359:2468\u20132476","journal-title":"N Engl J Med"},{"key":"804_CR19","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.ejmech.2010.02.047","volume":"45","author":"M Madhukar","year":"2010","unstructured":"Madhukar M, Sawraj S, Dev Sharma P (2010) Design, synthesis and evaluation of mutual prodrug of 4-biphenylacetic acid and quercetin tetramethyl ether (BPAeQTME) as gastrosparing NSAID. Eur J Med Chem 45:2591\u20132596","journal-title":"Eur J Med Chem"},{"key":"804_CR20","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/jm800156z","volume":"51","author":"M Malakoutikhah","year":"2008","unstructured":"Malakoutikhah M, Teixid\u00f3 M, Giralt E (2008) Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries. J Med Chem 51:4881\u20134889","journal-title":"J Med Chem"},{"key":"804_CR21","first-page":"459","volume":"20","author":"C Marrel","year":"1985","unstructured":"Marrel C, Boss G, Van De Waterbeemd H, Testa B, Cooper D, Jenner P, Marsden CD (1985) l-Dopa esters as potential prodrugs. Eur J Med Chem-Chim Ther 20:459\u2013465","journal-title":"Eur J Med Chem-Chim Ther"},{"key":"804_CR22","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1016\/j.ejmech.2008.12.027","volume":"44","author":"G Melagraki","year":"2009","unstructured":"Melagraki G, Afantitis A, Igglessi-Markopoulou O, Detsi A, Koufaki M, Kontogiorgis C, Hadjipavlou-Litina DJ (2009) Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts. Eur J Med Chem 44:3020\u20133026","journal-title":"Eur J Med Chem"},{"key":"804_CR23","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1021\/jm800239v","volume":"51","author":"SS More","year":"2008","unstructured":"More SS, Vince R (2008) Design, synthesis and biological evaluation of glutathione peptidomimetics as components of anti-Parkinson prodrugs. J Med Chem 51:4581\u20134588","journal-title":"J Med Chem"},{"key":"804_CR24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1042\/bj0550416","volume":"55","author":"T Nash","year":"1953","unstructured":"Nash T (1953) The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55:416\u2013421","journal-title":"Biochem J"},{"key":"804_CR25","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.bmcl.2008.09.065","volume":"18","author":"V Panteleon","year":"2008","unstructured":"Panteleon V, Kostakis IK, Marakos P, Pouli N, Andreadou I (2008) Synthesis and free radical scavenging activity of some new spiropyranocoumarins. Bioorg Med Chem Lett 18:5781\u20135784","journal-title":"Bioorg Med Chem Lett"},{"key":"804_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jalz.2009.06.003","volume":"5","author":"WM Pardridge","year":"2009","unstructured":"Pardridge WM (2009) Alzheimer\u2019s disease drug development and the problem of the blood-brain barrier. Alzheimers Dement 5:427\u2013432","journal-title":"Alzheimers Dement"},{"key":"804_CR27","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/jm070037v","volume":"50","author":"F Pinnen","year":"2007","unstructured":"Pinnen F, Cacciatore I, Cornacchia C, Sozio P, Iannitelli A, Costa M, Pecci L, Nasuti C, Cantalamessa F, Di Stefano A (2007) Synthesis and study of l-dopa-Glutathione codrugs as new anti-Parkinson agents with free radical scavenging properties. J Med Chem 50:2506\u20132515","journal-title":"J Med Chem"},{"key":"804_CR28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/jm801266x","volume":"52","author":"F Pinnen","year":"2009","unstructured":"Pinnen F, Cacciatore I, Cornacchia C, Sozio P, Cerasa LS, Iannitelli A, Nasuti C, Cantalamessa F, Sekar D, Gabbianelli R, Falcioni ML, Di Stefano A (2009) Codrugs linking l-dopa and sulphur-containing antioxidants: new pharmacological tools against Parkinson\u2019s disease. J Med Chem 52:559\u2013564","journal-title":"J Med Chem"},{"key":"804_CR29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00001756-199404000-00039","volume":"5","author":"TS Smith","year":"1994","unstructured":"Smith TS, Parker WD, Bennet JP (1994) l-Dopa increases nigral production of hydroxyl radicals in vivo: potential l-dopa toxicity? Neuroreport 5:1009\u20131011","journal-title":"Neuroreport"},{"key":"804_CR30","doi-asserted-by":"crossref","unstructured":"Sozio P, Iannitelli A, Cerasa LS, Cacciatore I, Cornacchia C, Giorgioni G, Ricciutelli M, Nasuti C, Cantalamessa F, Stefano Di (2008) A new l-dopa codrugs as potential antiparkinson agents. Arch Pharm 341:412\u2013417","DOI":"10.1002\/ardp.200700228"},{"key":"804_CR31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ardp.200900152","volume":"343","author":"P Sozio","year":"2010","unstructured":"Sozio P, D\u2019Aurizio E, Iannitelli A, Cataldi A, Zara S, Cantalamessa F, Nasuti C, Di Stefano A (2010) Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity. Arch Pharm 343:133\u2013142","journal-title":"Arch Pharm"},{"key":"804_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0968-0896(96)00213-1","volume":"5","author":"P St\u00f6ber","year":"1997","unstructured":"St\u00f6ber P, Schelhaas M, N\u00e4gele E, Hagenbuch P, R\u00e9tey J, Waldmann H (1997) Synthesis of characteristic lipopeptides of the human N-Ras protein and their evaluation as possible inhibitors of protein farnesyl transferase. Bioorg Med Chem 5:75\u201383","journal-title":"Bioorg Med Chem"},{"key":"804_CR33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/jp972787u","volume":"102","author":"A Vailaya","year":"1998","unstructured":"Vailaya A, Horv\u00e1th C (1998) Exothermodynamic relationships in liquid chromatography. J Phys Chem B 102:701\u2013718","journal-title":"J Phys Chem B"},{"key":"804_CR34","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/0960-894X(95)00379-8","volume":"5","author":"H Wang","year":"1995","unstructured":"Wang H, Lee J, Tsai M, Lu H, Hsu W (1995) Synthesis and pharmacological activities of a novel tripeptide mimetic dopamine prodrug. Bioorg Med Chem Lett 5:2195\u20132198","journal-title":"Bioorg Med Chem Lett"},{"key":"804_CR100","unstructured":"Yalkowsky SH, Morozowich W (1980) A physical chemical basis for the design of orally active prodrugs. In: Ariens EJ (ed) Drug design, vol 9. Academic Press, New York, pp 121\u2013135"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-010-0804-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-010-0804-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-010-0804-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T05:05:46Z","timestamp":1559797546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-010-0804-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,17]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["804"],"URL":"https:\/\/doi.org\/10.1007\/s00726-010-0804-z","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,17]]}}}